Meeting
2013 ASCO Annual Meeting
Analysis of recurrence risk by subtype in ≤1 cm breast tumors.
Authors
Sarah V. Colonna
University of Utah, Huntsman Cancer Institute, Salt Lake City, UT
Sarah V. Colonna , Ashantice K. Higgins , JoAnn Alvarez , Benjamin R. Saville , Julia Lawrence , Vandana Gupta Abramson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Triple-Negative Breast Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 1034)
DOI
10.1200/jco.2013.31.15_suppl.1034
Abstract #
1034
Poster Bd #
18A
Abstract Disclosures
Similar Posters
First Author: Assumpció López-Paradís
Poster
2023 ASCO Annual Meeting
Selective avoidance of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with HER-2 positive/triple negative breast cancer: Prospective, multi-center, single-arm study (ASLAN).
First Author: Jai Min Ryu
Poster
2023 ASCO Annual Meeting
Survival outcomes of young patients under 40 with breast cancer in Asian countries according to subtype: An international multicenter cohort study.
First Author: Jinyong Kim
Poster
2023 ASCO Annual Meeting
HER2-low breast cancer brain metastases: Incidence and treatment implications.
First Author: Rania Chehade